MHRA announces new regulatory recognition routes for medicines licensing using approvals from various countries

The UK MHRA has announced today that new regulatory recognition routes for medicines will be established using approvals from the following countries: This means that patients will have access to safe and effective medicines that have been approved by trusted…

Read MoreMHRA announces new regulatory recognition routes for medicines licensing using approvals from various countries

UK to introduce first-of-its-kind framework to make it easier to manufacture innovative medicines at the point of care

In 2021, the MHRA held a public consultation seeking views on a legislative proposal to introduce a new regulatory framework for the manufacture and supply of Point of Care (POC) products. This post is about the formal government response to that consultation.…

Read MoreUK to introduce first-of-its-kind framework to make it easier to manufacture innovative medicines at the point of care